Jump To Top

groundrushairsports

You are here:
Home / Health News / Moderna COVID-19 vaccine gets Swiss approval for 12- to 17-year-olds

Moderna COVID-19 vaccine gets Swiss approval for 12- to 17-year-olds

FILE PHOTO: Vial labelled “Moderna coronavirus disease (COVID-19) vaccine” placed on displayed Moderna logo is seen in this illustration picture taken March 24, 2021. REUTERS/Dado Ruvic/Illustration

ZURICH (Reuters) – Swissmedic has approved the Moderna COVID-19 vaccine for 12- to 17-year-olds, the Swiss agency said on Monday.

“Swissmedic has carefully examined the application from Moderna Switzerland GmbH for the indication extension and has extended the temporary authorisation for the Spikevax COVID-19 vaccines from Moderna for the prevention of the coronavirus disease in adolescents aged 12 to 17,” it said here on its website.

Source: Read Full Article

Related posts:
  1. Swiss church bells mark year since first COVID-19 death
  2. WHO's Tedros urges countries and drug makers to get more vaccine to poorer countries
  3. Vietnam detects hybrid of Indian and UK COVID-19 variant
  4. Royal Caribbean says two guests test positive for COVID-19 on Celebrity Millennium cruise (June 10)
  • Posted on August 9, 2021
RELATED NEWS
The Ultimate Guide to Hydrafacial Treatment
Inside the Pentagon’s painfully slow effort to clean up decades of PFAS contamination
Stem cell heart tissue model paves the way for better understanding of tachycardia
Antimicrobial resistance leads to more deaths and illnesses in the WHO African region than anywhere else: Study